Items tagged with Scientific research
InveniAI announces strategic partnership with TB Alliance to advance the development of transformative therapies for TB (post)
Guilford, Conn., June 2, 2020 - InveniAI® LLC, a global leader pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across drug discovery and development, is pleased to announce a strategic partnership with TB Alliance, a non-profit organization dedicated to the discovery, development, and delivery of better, faster-acting and affordable tuberculosis (TB) drugs. TB Alliance will make use of InveniAI’s AI and machine learning platform, AlphaMeld®, to identify and accelerate transformative therapies for the management, treatment, and cure of TB, which remains the world’s top infectious disease killer.
COVID-19’s interaction with HIV and TB investigated (post)
A research program, launched by the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) at the University of Cape Town, will investigate the interaction between the COVID-19 pandemic and common endemic infectious diseases in the South African context - HIV and TB.
HIV and TB increase death risk from COVID-19, study finds—but not by much (post)
CAPE TOWN, SOUTH AFRICA —Living with HIV or active tuberculosis (TB) increases a person’s likelihood of dying from COVID-19, preliminary data from South Africa show. However, the effect is small compared with other known risk factors such as old age and diabetes.
Together they stay alive longer: TB bacteria persist longer in groups (post)
The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air. This was the result of a study by the Leibniz Research Alliance INFECTIONS, which was published in the scientific journal Scientific Reports on Monday.
Scientists find ‘missing link’ and move ‘a step closer’ to finding a cure for TB (post)
Scientists from the University of Bradford say they are ‘a step closer to finding a vaccine’ for tuberculosis after discovering a new variant of the disease in Africa.
Research reveals more about path bacterial pathogen travels to cause TB (post)
EL PASO, Texas - Biology students and faculty members from The University of Texas at El Paso have discovered a new target for tuberculosis drug development. Their study recently was published in the Journal of Biological Chemistry, a publication of the American Society of Biochemistry and Molecular Biology (ASBMB).
Sydney researchers test TB vaccine combination for COVID-19 (post)
Sydney researchers are taking an innovative approach to designing potential COVID-19 vaccines - using a tuberculosis vaccine to deliver components of the SARS-CoV-2 virus. Early results from pre-clinical testing in mice are promising.
Page 49 of 74 · Total posts: 0
←First 48 49 50 Last→